Obatala Sciences Closes $3M Series A Funding


Obatala Sciences, a New Orleans, LA-based biotechnology corporate, raised $3M in Sequence A investment.

The spherical was once led by means of ĂȘtre Project Capital and Ochsner Lafayette Common Healthcare Innovation Fund II with participation from Benson Capital Companions, Raise Capital Fund, and The Hackett-Robertson-Tobe Staff.

The corporate intends to make use of the finances to additional the commercialization of its research-enabling merchandise and platform for drug discovery and construction.

Led by means of CEO Minutiae Frazier, Obatala Sciences permits variety in medical examine and accelerates the improvement of remedies for sicknesses like weight problems, diabetes, and most cancers, and advance examine in tissue engineering and regenerative drugs. The corporate has a longtime pipeline of human-derived hydrogels for rising cells in three-D, grownup human stem cells from a biobank of numerous populations, media for rising and differentiating cells, and whole tissue chip kits, similar to fat-on-a-chip techniques, that are these days to be had, and pancreas-on-a-chip techniques, that are below construction.



Leave a Comment